Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:35 pm Purchase | 2024-09-30 | 13G | Palisade Bio, Inc. PALI | Armistice Capital, LLC | 125,692 9.990% | 125,692 (New Position) | Filing History |
| 2024-02-14 2:54 pm Purchase | 2023-12-31 | 13G | Palisade Bio, Inc. PALI | Armistice Capital, LLC | 32,461 4.990% | 13,724 (+73.25%) | Filing History |
| 2024-02-13 8:10 pm Sale | 2023-12-31 | 13G | Palisade Bio, Inc. PALI | Lind Global Fund II LP | 10,557 1.700% | -38,997 (-78.70%) | Filing History |
| 2024-02-09 4:03 pm Sale | 2023-12-31 | 13G | Palisade Bio, Inc. PALI | L1 Capital Global Opportunities Master Fund, Ltd. | 0 0.000% | -38,997 (Position Closed) | Filing History |
| 2024-02-06 10:29 am Purchase | 2023-12-31 | 13G | Palisade Bio, Inc. PALI | Mitchell P. Kopin | 12,035 1.900% | 3,296 (+37.72%) | Filing History |
| 2023-09-15 4:42 pm Purchase | 2023-09-07 | 13G | Palisade Bio, Inc. PALI | L1 Capital Global Opportunities Master Fund, Ltd. | 38,997 6.400% | 38,997 (New Position) | Filing History |
| 2023-09-15 4:30 pm Purchase | 2023-09-11 | 13G | Palisade Bio, Inc. PALI | Lind Global Fund II LP | 49,554 7.900% | 47,488 (+2298.79%) | Filing History |
| 2023-02-14 1:14 pm Purchase | 2022-12-31 | 13G | Palisade Bio, Inc. PALI | Armistice Capital, LLC | 18,737 9.990% | 18,737 (New Position) | Filing History |
| 2023-02-14 12:26 pm Unchanged | 2022-12-31 | 13G | Palisade Bio, Inc. PALI | Altium Capital Management LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-13 4:34 pm Purchase | 2022-12-31 | 13G | Palisade Bio, Inc. PALI | Lind Global Fund II LP | 2,066 1.400% | 2,066 (New Position) | Filing History |
| 2023-02-08 06:05 am Purchase | 2022-12-31 | 13G | Palisade Bio, Inc. PALI | Mitchell P. Kopin | 8,739 5.700% | 8,739 (New Position) | Filing History |
| 2022-08-22 06:01 am Purchase | 2022-08-16 | 13G | Palisade Bio, Inc. PALI | Mitchell P. Kopin | 10,137 9.990% | 9,876 (+3776.20%) | Filing History |
| 2022-08-18 5:00 pm Purchase | 2022-08-16 | 13G | Palisade Bio, Inc. PALI | Lind Global Fund II LP | 5,333 6.200% | 5,333 (New Position) | Filing History |
| 2022-02-14 3:09 pm Sale | 2022-02-02 | 13G | Palisade Bio, Inc. PALI | Altium Capital Management LLC | 4,467 9.990% | -859 (-16.13%) | Filing History |
| 2022-02-14 2:37 pm Purchase | 2021-12-31 | 13G | Palisade Bio, Inc. PALI | Altium Capital Management LLC | 5,326 4.990% | 3,558 (+201.25%) | Filing History |
| 2022-02-11 07:44 am Purchase | 2021-12-31 | 13G | Palisade Bio, Inc. PALI | Mitchell P. Kopin | 262 1.400% | 262 (New Position) | Filing History |
| 2021-08-30 5:23 pm Purchase | 2021-08-19 | 13D | Palisade Bio, Inc. PALI | Yuma Regional Medical Center | 2,997 19.000% | 2,997 (New Position) | Filing History |
| 2021-05-10 9:03 pm Purchase | 2021-04-29 | 13G | Palisade Bio, Inc. PALI | Altium Capital Management LLC | 1,768 9.820% | 1,768 (New Position) | Filing History |
| 2021-02-10 8:07 pm Sale | 2020-12-31 | 13G | SENECA BIOPHARMA INC SNCA | RENAISSANCE TECHNOLOGIES LLC | 167,512 0.970% | -91,372 (-35.29%) | Filing History |
| 2021-02-10 5:33 pm Purchase | 2020-12-31 | 13G | SENECA BIOPHARMA INC SNCA | Hudson Bay Capital Management LP | 857,985 4.730% | 428,856 (+99.94%) | Filing History |